Xia X - Search Results

1

Preferential expression of hPGFS in primary SCCHN and tumour cell lines derived from respiratory and digestive organs.

Li S, Hanna E, Breau R, Ratanatharathorn V, Xia X, Suen J. Li S, et al. Among authors: xia x. Br J Cancer. 2004 Mar 8;90(5):1093-9. doi: 10.1038/sj.bjc.6601636. Br J Cancer. 2004. PMID: 14997212 Free PMC article.

2

A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck.

Hanna E, Shrieve DC, Ratanatharathorn V, Xia X, Breau R, Suen J, Li S. Hanna E, et al. Among authors: xia x. Cancer Res. 2001 Mar 15;61(6):2376-80. Cancer Res. 2001. PMID: 11289099

3

Enhancement of reporter gene detection sensitivity by insertion of specific mini-peptide-coding sequences.

Cutrera J, Dibra D, Xia X, Li S. Cutrera J, et al. Among authors: xia x. Cancer Gene Ther. 2010 Feb;17(2):131-40. doi: 10.1038/cgt.2009.54. Epub 2009 Aug 28. Cancer Gene Ther. 2010. PMID: 19713998 Free PMC article.

4

Intramuscular electroporation delivery of IFN-alpha gene therapy for inhibition of tumor growth located at a distant site.

Li S, Zhang X, Xia X, Zhou L, Breau R, Suen J, Hanna E. Li S, et al. Among authors: xia x. Gene Ther. 2001 Mar;8(5):400-7. doi: 10.1038/sj.gt.3301418. Gene Ther. 2001. PMID: 11313817

5

Regression of tumors by IFN-alpha electroporation gene therapy and analysis of the responsible genes by cDNA array.

Li S, Xia X, Zhang X, Suen J. Li S, et al. Among authors: xia x. Gene Ther. 2002 Mar;9(6):390-7. doi: 10.1038/sj.gt.3301645. Gene Ther. 2002. PMID: 11960315

6

Competitive electroporation formulation for cell therapy.

Flanagan M, Gimble JM, Yu G, Wu X, Xia X, Hu J, Yao S, Li S. Flanagan M, et al. Among authors: xia x. Cancer Gene Ther. 2011 Aug;18(8):579-86. doi: 10.1038/cgt.2011.27. Epub 2011 Jun 10. Cancer Gene Ther. 2011. PMID: 21660061 Free PMC article.

7

Radiosensitivity of canine osteosarcoma cells transfected with wild-type p53 in vitro.

Shiomitsu K, Sajo E, Xia X, Hunley DW, Mauldin GE, Li S, Mauldin GN. Shiomitsu K, et al. Among authors: xia x. Vet Comp Oncol. 2008 Sep;6(3):193-200. doi: 10.1111/j.1476-5829.2008.00160.x. Vet Comp Oncol. 2008. PMID: 19178679

8

Intricacies for posttranslational tumor-targeted cytokine gene therapy.

Cutrera J, Dibra D, Satelli A, Xia X, Li S. Cutrera J, et al. Among authors: xia x. Mediators Inflamm. 2013;2013:378971. doi: 10.1155/2013/378971. Epub 2013 Nov 27. Mediators Inflamm. 2013. PMID: 24369443 Free PMC article.

9

FABP5 regulates ROS-NLRP3 inflammasome in glutamate-induced retinal excitotoxic glaucomatous model.

Zeng Z, You M, Fan C, Jang J, Xia X. Zeng Z, et al. Among authors: xia x. FASEB J. 2025 Jan 15;39(1):e70281. doi: 10.1096/fj.202400435R. FASEB J. 2025. PMID: 39792326

10

Three-Level Nanoparticle Rocket Strategy for Colorectal Cancer Therapeutics in Photothermal Therapy, Inflammation Modulation, and Cuproptosis Induction.

Shang W, Xia X, Zhu Y, Chen Q, Rao X, Huang L, Tu Y, Chen H, Tian H, Lin M, Zheng Y, Liu B, Li Z, Han S, Liu J. Shang W, et al. Among authors: xia x. Adv Healthc Mater. 2025 Jan 10:e2403939. doi: 10.1002/adhm.202403939. Online ahead of print. Adv Healthc Mater. 2025. PMID: 39790067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,058 results

Search Page

Filters